Literature DB >> 35468612

Letter on the Published Article "Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician".

Tomoyuki Kawada1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35468612      PMCID: PMC9485966          DOI: 10.1159/000524708

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   2.132


× No keyword cloud information.
Dear Editor, I read with great interest the article titled “Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician” by Falsetti et al. [1]. The authors reviewed the relationship between chronic respiratory disorders and chronic neurodegenerative diseases with special reference to risk factors and interactions of these two disorders. Chronic hypoxia is the important factor for the pathogenesis of neurodegenerative disorders, expressing cognitive impairment, and obstructive sleep apnea syndrome (OSAS) is the major chronic hypoxia-causing disorder. To specify the underlying mechanisms, amyloid β metabolism, tau phosphorylation, inflammation, and oxidative stress have been considered as the cause of neurodegeneration in the brain [2]. I have a comment regarding the study with special reference to OSAS treatment and cognitive impairment. Liguori et al. [3] evaluated the long-term effects of continuous positive airway pressure (CPAP) treatment in patients with OSAS and mild cognitive impairment or Alzheimer's disease (AD). Significant worse cognitive and functional performances were observed in patients with the CPAP nonadherent group. By keeping a stable estimation, Dunietz et al. [4] reported with an enough number of samples that CPAP adherence was significantly associated with lower odds of incident diagnoses of AD. Although these two papers adopted a retrospective study design, CPAP treatment was effective to reduce the risk of cognitive and functional performances. On the contrary, Fernandes et al. [5] reviewed the association between OSA and risk of dementia to specify whether OSA is a risk factor for developing mild cognitive impairment and AD in the middle-aged and older populations. There were inconsistent results regarding the effectiveness of CPAP treatment to suppress the progression of cognitive decline in AD patients and delaying effect of the conversion to AD in MCI patients. Intervention studies are needed to verify the causal association.

Conflict of Interest Statement

The author has no conflicts of interest to declare.

Funding Sources

The author received no financial support for the research, authorship, and publication of this article.
  5 in total

Review 1.  Pathological Impacts of Chronic Hypoxia on Alzheimer's Disease.

Authors:  Feng Zhang; Long Niu; Song Li; Weidong Le
Journal:  ACS Chem Neurosci       Date:  2018-11-26       Impact factor: 4.418

Review 2.  Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician.

Authors:  Lorenzo Falsetti; Giovanna Viticchi; Vincenzo Zaccone; Nicola Tarquinio; Lorenzo Nobili; Cinzia Nitti; Aldo Salvi; Gianluca Moroncini; Mauro Silvestrini
Journal:  Med Princ Pract       Date:  2021-07-07       Impact factor: 2.132

3.  Obstructive sleep apnea treatment and dementia risk in older adults.

Authors:  Galit L Dunietz; Ronald D Chervin; James F Burke; Alan S Conceicao; Tiffany J Braley
Journal:  Sleep       Date:  2021-09-13       Impact factor: 6.313

4.  Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration?

Authors:  Claudio Liguori; Riccardo Cremascoli; Michelangelo Maestri; Mariana Fernandes; Francesca Izzi; Gloria Tognoni; Federica Scarpina; Gabriele Siciliano; Nicola Biagio Mercuri; Lorenzo Priano; Enrica Bonanni; Fabio Placidi
Journal:  Sleep Breath       Date:  2021-02-22       Impact factor: 2.816

Review 5.  The Importance of Diagnosing and the Clinical Potential of Treating Obstructive Sleep Apnea to Delay Mild Cognitive Impairment and Alzheimer's Disease: A Special Focus on Cognitive Performance.

Authors:  Mariana Fernandes; Fabio Placidi; Nicola Biagio Mercuri; Claudio Liguori
Journal:  J Alzheimers Dis Rep       Date:  2021-06-17
  5 in total
  1 in total

1.  Response to Letter on "Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician".

Authors:  Lorenzo Falsetti; Giovanna Viticchi; Vincenzo Zaccone; Nicola Tarquinio; Lorenzo Nobili; Cinzia Nitti; Aldo Salvi; Gianluca Moroncini; Mauro Silvestrini
Journal:  Med Princ Pract       Date:  2022-04-25       Impact factor: 2.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.